Omeprazole promotes gastric epithelial cell migration

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 5, 2008, Pages 655-660

  Ng, Ka Man ^a,c   Cho, Chi Hin ^b   Chang, Full Young ^a,c   Luo, Jiing Chyuan ^a,c   Lin, Han Chieh ^a,c   Lin, Hsiao Yi ^a,c   Chi, Chin Wen ^a,c   Lee, Shou Dong ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; CYCLOOXYGENASE 2; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTON PUMP INHIBITOR;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EPITHELIUM CELL; FLOW CYTOMETRY; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; STOMACH ULCER; ULCER HEALING; WESTERN BLOTTING;

ANIMALS; ANTI-ULCER AGENTS; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; EPITHELIAL CELLS; GASTRIC MUCOSA; OMEPRAZOLE; PROTON PUMPS; RATS;

EID: 42549132273     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.5.0012     Document Type: Article

References (37)

1. Agrawal, N. M., Campbell, D. R., Safdi, M. A., Lukasik, N. L., Huang, B., Haber, M. M. (2000) Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcer. Arch. Intern. Med. 160: 1455-1461
2. Appleyard, C. B., McCafferty, D. M., Tigley, A. W., Swain, M. G., Wallace, J. L. (1996) Tumor necrosis factor medication of NSAIDs-induced gastric damage: role of leukocyte adherence. Am. J. Physiol. Gastrointest. Liver Physiol. 270: G42-48
3. Blandizzi, C., Natale, G., Gherardi, G., Lazzeri, G., Marveggio, C., Colucci, R., Carignani, D., Del-Tacca, M. (1999) Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig. Dis. Sci. 44: 2039-2050
4. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 278: 35 451-35 457
5. Cederberg, C., Thomson, A. B., Mahachai, V., Westin, J. A., Kirdeikis, P., Fisher, D., Zuk, L., Marriage, B. (1992) Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology 103: 913-918
6. Cullen, D., Bardhan, K. D., Eisner, M., Kogut, D. G., Peacock, R. A., Thomson, J. M., Hawkey, C. J. (1998) Primary gastroduodenal prophylaxis with omeprazole for NSAID users. Aliment. Pharmacol. Ther. 12: 135-140
7. Ekstrom, P., Carling, L., Wetterhus, S., Wingren, P. E., Anker-Hansen, O., Lundegardh, G., Thorhallsson, E., Unge, P. (1996) Prevention of peptic ulcer and dyspepsia symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy - a Nordic multicentre study. Scand. J. Gastroenterol. 31: 753-758
8. Fiorucci, S., Antonelli, E., Morelli, O., Morelli, A. (1993) Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. Ital. J. Gastroenterol. Hepatol. 31 (Suppl. 1): S6-13
9. Handa, O., Yoshida, N., Fujita, N., Tanaka, Y., Ueda, M., Takagi, T., Kokura, S., Naito, Y., Okanoue, T., Yoshikawa, T. (2006) Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitor. Inflamm. Res. 55: 476-480
10. Hawkey, C. J., Karrasch, J. A., Szczepanski, L., Walker, D. G., Barkun, A., Swannell, A. J., Yeomans, N. D. (1998) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. N. Engl. J. Med. 338: 727-734
11. Jones, M. K., Wang, H., Tarnawski, A. S. (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 5: 1418-1423
12. Luo, J. C., Shin, V. Y., Liu, E. S. L., So, W. H. L., Ye, Y. N., Chang, F. Y., Cho, C. H. (2003) Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J. Pharmacol. Exp. Ther. 307: 692-698
13. Luo, J. C., Shin, V. Y., Liu, E. S. L., Ye, Y. N., Wu, W. K. K., So, W. H. L., Chang, F. Y., Cho, C. H. (2004) Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur. J. Pharmacol. 485: 275-281
14. Luo, J. C., Shin, V. Y., Yang, Y. H., Wu, W. K. K., Ye, Y. N., So, W. H. L., Chang, F. Y., Cho, C. H. (2005) Tumor necrosis factor-α stimulates gastric epithelial cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G32-38
15. Luo, J. C., Chi, C. W., Lin, H. Y., Chang, F. Y., Lu, C. L., Chen, C. Y., Lee, S. D. (2007) Dexamethasone inhibits epidermal growth factor-stimulated gastric epithelial cell proliferation. J. Pharmacol. Exp. Ther. 320: 687-694
16. Milani, S., Calabro, A. (2001) Role of growth factors and their receptors in gastric ulcer healing. Microsc. Res. Tech. 53: 360-371
17. Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T., Kasuga, M. (1997) Introduction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112: 387-397
18. Netzer, P., Halter, F., Ma, T. Y., Hoa, N., Nguyen, N., Nakamura, T., Tarnawski, A. S. (2003) Interactions of hepatocyte growth factor and non-steroidal anti-inflammatory drugs during gastric epithelial wound healing. Digestion 67: 118-128
19. Okada, A., Kinoshita, Y., Waki, S., Fukui, H., Maekawa, T., Matsushima, Y., Kawanami, C., Kishi, K., Nakata, H., Wang, H. Y., Hassan, S., Chiba, T. (1998) Rat gastric mucosal cells express ICAM-I and proinflammatory cytokines during indomethacin-induced mucosal injury. J. Lab. Clin. Med. 131: 538-547
20. Pai, R., Szabo, I. L., Giap, A. Q., Kawanaka, H., Tarnawski, A. S. (2001) Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signal. Life Sci. 69: 3055-3071
21. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8: 289-293
22. Peskar, B. M. (2002) Cyclooxygenase inhibitor, a foe or a friend in the mucosa protection and repair. In: Cho, C. H., Wang, J. Y. (eds) Gastrointestinal mucosal repairing and experimental therapeutics, 1st edn. Karger, Basel, pp 166-179
23. Peskar, B. M., Maricic, N., Gretzer, B., Schuligoi, R., Schmassmann, A. (2001) Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci. 69: 2993-3003
24. Schmassmann, A. (1998) Mechanisms of ulcer healing and effects of nonsteroidial anti-inflammatory drugs. Am. J. Med. 104: 43S-51S
25. + channel expression. Eur. J. Pharmacol. 444: 115-121
26. Silen, W., Ito, S. (1985) Mechanisms for rapid re-epithelialization of gastric mucosal surface. Annu. Rev. Physiol. 47: 217-229
27. Suzuki, M., Mori, M., Miura, S., Suematsu, M., Fukumura, D., Kimura, H., Ishii, H. (1996) Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free. Radic. Biol. Med. 21: 727-731
28. Szabo, S., Khomenko, T., Gombos, Z., Deng, X. M., Jadus, M. R., Yoshida, M. (2000) Review article: transcription factors and growth factors in ulcer healing. Aliment. Pharmacol. Ther. 14 (Suppl. 1): 33-43
29. Tarnawski, A. S. (2005) Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig. Dis. Sci. 50 (Suppl. 1): S24-33
30. Tarnawski, A., Szabo, I. L., Husain, S. S., Soreghan, B. (2001) Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J. Physiol. 95: 337-344
31. Terada, Y., Isoshita, S., Nakashima, O., Kuwahara, M., Sasaki, S., Marumo, F. (1999) Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 56: 1258-1261
32. Tsuji, S., Sun, W. H., Tsujii, M., Kawai, N., Kimura, A., Kakiuchi, Y., Yasumaru, S., Komori, M., Murata, H., Sasaki, Y., Kawano, S., Hori, M. (2002) Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats. J. Pharmacol. Exp. Ther. 303: 1301-1308
33. Wallace, J. L., McKnight, W., Reuter, B., Vergnolle, N. (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119: 706-714
34. Wolfe, M. M., Lichtenstein, D. R., Singh, G. (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340: 1888-1899
35. Yeomans, N. D., Tulassay, Z., Juhasz, L., Racz, I., Howard, J. M., van Rensburg, C. J., Swannell, A. J., Hawkey, C. J. (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N. Engl. J. Med. 338: 719-726
36. Yoo, J., Lotz, M. M., Matthews, J. B. (2002) Cytokines in restitution. In: Cho, C. H., Wang, J. Y. (eds). Gastrointestinal mucosal repairing and experimental therapeutics, 1st edn. Karger, Basel, pp 14-28
37. Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., Kondo M. (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors: inhibitory effects on neutrophil-endothelial cell interaction. Aliment. Pharmacol. Ther. 14 (Suppl. 1): 74-81